Skip to content
Luke O. Cheung, M.D.

Luke O. Cheung, M.D.

Geriatrics & Aging

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

About Me

Certified Specialties

Geriatric Medicine - American Board of Internal Medicine

Internal Medicine - American Board of Internal Medicine

Faculty Appointments

Professor of Clinical Medicine - Department of Medicine, Geriatrics/Aging (SMD)

Credentials

Residency & Fellowship

Fellowship, Pulmonary Disease, University of Wisconsin Hospital and Clinics. 1985 - 1985

Residency, Internal Medicine, Rochester General Hospital. 1983 - 1985

Internship, Internal Medicine, Hospital of St. Raphael Oral/Maxillofacial. 1982 - 1983

Education

MD | University Of The East Ramon Magsaysay Memorial Medical Center (Philippines). 1982

Awards

Division of Geriatrics & Aging, Educator of the Year 2019. 2019 - 2019

2015 ICARE Bronze Star Award. 2014 - 2015

2014 ICARE Bronze Star Award. 2013 - 2014

Patient & Family Center Care Award- 89% tile rank on Patient Satisfaction Score. 2012 - 2013

Patient & Family Center Care Award-99% tile Rank on Patient Satisfaction Score. 2010 - 2011

Fellow, American College of Physician. 1995

Departmental Honor, 1977- Biology Department, St. Olaf College, Minnesota.. 1977

Research

CURRENT AND PAST RESEARCH INTERESTS
Geriatric Emergency Care:
(i) Functional assessment of elderly patients in ED
(ii) Altered disease presentations in the elderlies
(iii) Use of medications in the elderlies- polypharmacy, altered physiological & pharmacological response to med...
CURRENT AND PAST RESEARCH INTERESTS
Geriatric Emergency Care:
(i) Functional assessment of elderly patients in ED
(ii) Altered disease presentations in the elderlies
(iii) Use of medications in the elderlies- polypharmacy, altered physiological & pharmacological response to medications & drug interactions-e.g. the use of Fibrinolytic vs. the emergency use of PTCA in the elderlies, the use of antithrombotic therapy (non-fractionated heparin versus low molecular weight heparin) & the use of antiplatelet therapy (GPIIA/IIIB Inhibitor) for Acute Coronary Syndromes in the age groups 75 or older.
(iv) Use of fibrinolytics in the treatment of Acute Ischemic Stroke in the Elderlies- Viability rather than age.

Thrombolytic Therapy in the city of greater Rochester
(i) How to improve Door to Drug time in giving thrombolytic in the emergency department?
(ii) How to improve Door to Balloon time with primary angioplasty?

The efficacy and safety of Outpatient versus OBS stress testing for low risk chest pain patients

Risk stratification of CHF patients who are candidates for OBS, and its efficacy and safety versus traditional inpatient management

Treatment of cellulitis in OBS, use of Vancomycin for 2 days and discharge home on Clindamycin + Bactrim or Doxycycline versus Clindamycin + Bactrim or Doxycycline during OBS and discharge home with the same regimen

The use of Decadron for acute radiculopathic pain versus epidural versus placebo